Computational analysis of the genetic and environmental contributions to disease-related human phenotypes: From predicting adverse lipid response of HIV patients receiving antiretroviral therapy to genome-wide association studies of cardiovascular and lipid related disorders
Year: 2010
Type: dissertation
Abstract: Genetic variants influence the risk to develop certain diseases or give rise to differences in drug response. Recent progresses in cost-effective, high-throughput genome-wide techniques, such as microarrays measuring Single Nucleotide Polymorphisms (SNPs), have facilitated genotyping of large clinical and population cohorts. Combining the massive genotypic data with measurements of phenotypic traits allows for the determination of genetic differences that explain, at least in part, the phenotypic variations within a population. So far, models combining the most significant variants can only explain a small fraction of the variance, indicating the limitations of current models. In particular, researchers have only begun to address the possibility of interactions between genotypes and the environment. Elucidating the contributions of such interactions is a difficult task because of the large number of genetic as well as possible environmental factors.In this thesis, I worked on several projects within this context. My first and main project was the identification of possible SNP-environment interactions, where the phenotypes were serum lipid levels of patients from the Swiss HIV Cohort Study (SHCS) treated with antiretroviral therapy. Here the genotypes consisted of a limited set of SNPs in candidate genes relevant for lipid transport and metabolism. The environmental variables were the specific combinations of drugs given to each patient over the treatment period. My work explored bioinformatic and statistical approaches to relate patients' lipid responses to these SNPs, drugs and, importantly, their interactions. The goal of this project was to improve our understanding and to explore the possibility of predicting dyslipidemia, a well-known adverse drug reaction of antiretroviral therapy. Specifically, I quantified how much of the variance in lipid profiles could be explained by the host genetic variants, the administered drugs and SNP-drug interactions and assessed the predictive power of these features on lipid responses. Using cross-validation stratified by patients, we could not validate our hypothesis that models that select a subset of SNP-drug interactions in a principled way have better predictive power than the control models using "random" subsets. Nevertheless, all models tested containing SNP and/or drug terms, exhibited significant predictive power (as compared to a random predictor) and explained a sizable proportion of variance, in the patient stratified cross-validation context. Importantly, the model containing stepwise selected SNP terms showed higher capacity to predict triglyceride levels than a model containing randomly selected SNPs. Dyslipidemia is a complex trait for which many factors remain to be discovered, thus missing from the data, and possibly explaining the limitations of our analysis. In particular, the interactions of drugs with SNPs selected from the set of candidate genes likely have small effect sizes which we were unable to detect in a sample of the present size (<800 patients).In the second part of my thesis, I performed genome-wide association studies within the Cohorte Lausannoise (CoLaus). I have been involved in several international projects to identify SNPs that are associated with various traits, such as serum calcium, body mass index, two-hour glucose levels, as well as metabolic syndrome and its components. These phenotypes are all related to major human health issues, such as cardiovascular disease. I applied statistical methods to detect new variants associated with these phenotypes, contributing to the identification of new genetic loci that may lead to new insights into the genetic basis of these traits. This kind of research will lead to a better understanding of the mechanisms underlying these pathologies, a better evaluation of disease risk, the identification of new therapeutic leads and may ultimately lead to the realization of "personalized" medicine.
Source: IRIS
Author: Marek, D.
Institution: University of Lausanne
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
Funders: National Science Foundation, Donald W. Reynolds Foundation, Amgen, AstraZeneca, GlaxoSmithKline, McKnight Foundation, Hjerteforeningen, Foundation for Cardiovascular Research, Helsingin ja Uudenmaan Sairaanhoitopiiri, Juvenile Diabetes Research Foundation United States of America, National Alliance for Research on Schizophrenia and Depression, Yrjö Jahnssonin Säätiö, Jalmari ja Rauha Ahokkaan Säätiö, Finska Läkaresällskapet, Wellcome Trust, Scottish Government, Broad Institute, Folkhälsanin Tutkimussäätiö, Cancer Research UK, National Institute for Health and Care Research, British Heart Foundation, Diabetes UK, European Commission, Healthway, Agency for Science, Technology and Research, Deutsche Forschungsgemeinschaft, Fondation Leducq, Institut National de la Santé et de la Recherche Médicale, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Stiftelsen för Strategisk Forskning, Kela, Bundesministerium für Bildung und Forschung, Cancerfonden, Technische Universität Dresden, Erasmus Medisch Centrum, Ministero della Salute, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Lundbeckfonden, Biomedicum Helsinki-säätiö, Hjärt-Lungfonden, Juho Vainion Säätiö, Karolinska Institutet, Knut och Alice Wallenbergs Stiftelse, Novo Nordisk, Päivikki ja Sakari Sohlbergin Säätiö, Signe ja Ane Gyllenbergin Säätiö, Stockholms Läns Landsting, Vetenskapsrådet, Samfundet Folkhälsan, Augustinus Fonden, Sydäntutkimussäätiö, Göteborgs Läkaresällskap, Lastentautien Tutkimussäätiö, Oulun Yliopisto, Fondation Leenaards, Université de Lausanne, Svenska Kulturfonden, Svenska Läkaresällskapet, Paavo Nurmen Säätiö, Fondation Institut de Cardiologie de Montréal, Institut de Cardiologie de Montréal, Hjartavernd, H. Lundbeck A/S, Diabetestutkimussäätiö, Centre for Medical Systems Biology, Diabetesforeningen, National Institutes of Health, Goddard Space Flight Center, Medical Research Council, Cambridge Institute for Medical Research, University of Cambridge, National Health and Medical Research Council, NIHR Cambridge Biomedical Research Centre, Norwegian Institute of Public Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Research Resources
Awards: From modules to models: towards a better understanding of disease through advanced analysis of large-scale data, G1044594144, G1077033501, G1106494173, G1140801657, G1147136077, Opening Estonian Genome Project for European Research Area, Sustainable and integrated production of liquid biofuels, bioenergy and green chemicals from glycerol in biorefineries, Precision Polymerization, G128866762, Efficient Numerical Methods for Partial Differential Equations, Das kulturelle Missverständnis., Verbundprojekt Molekulare Mechanismen der Adipositas - funktionelle Studien von Adipositas Kandidatengenen (WB2-B, WB3-C), G1495020029, G151562090, Pharmacogenetic analysis of the cardiovascular response in mice, G1689944598, Validation and Replication of Genes Associated with Common Human Disease Using Australian Twin Families, G178382592, Indikatoren der schweizerischen Wettbewerbsfähigkeit, G1854461006, G199559702, The effect of sequence variation on chromatin structure and transcription, G2145160299, G2238725043, Cardiovascular diseases and psychiatric disorders in the general population: a prospective follow-up study, Cohort Study of Genetic Susceptibility to Breast Cancer, G2439840495, Institute for Clinical and Translational Research (UL1), Function and regulation of the universally conserved heat shock response, Verbundprojekt: Kompetenznetz Adipositas: Verbund MEMORI: TP1 und TP2, Gene-gene interactions for hypertension candidate genes in a Swiss population-based sample (PROSPER), G2762069773, G277616795, G2830669520, tweeling onderzoek, met een focus op gedrag en depressie, G2957143966, G300339986, G3012480970, G3207356259, Verbundprojekt Molekulare Mechanismen der Adipositas - Zentrale statistische Genomik und Datenmanagement (Teilprojekt 15a), Verbundprojekt Molekulare Mechanismen der Adipositas - Gen Validierung in epidemiologischen Kohorten und Fall-Kontrollstudien (WB2-A) und Funktionelle Studien von adipositasrelevanten Genen (WB3-A), G3362311673, G3367174484, G3479338925, Gene-gene interactions for hypertension candidate genes in a Swiss population-based sample (zu PROSPER), G3540777072, G3602225402, G374919288, Verbundprojekt Molekulare Mechanismen der Adipositas - (WB2-D, WB3-B), G3814398992, G3839646794, G391725838, Verbundprojekt Molekulare Mechanismen der Adipositas - Identifizierung von Kandidatengenen, Statistik und Koordination (Teilprojekt 1, WB2-C, WB3-C, Teilprojekt15b, Teilprojekt16), G393177772, An object-based evaluation of the forecast uncertainty of Mediterranean cyclones and their associated surface weather extremes, Dietary and Hormonal Determinants of Cancer in Women, G4010296779, Genome-wide combined linkage-association scan of multiply phenotyped twin sibships, G4050880153, Pigmentation genes and melanoma risk, European Network for Genetic-Epidemiological Studies: building a method to dissect complex genetic traits, using essential hypertension as a disease model, G4330096051, G4507648799, G459060772, Association Screen of Migraine Candidate Genes, G4603488609, G4652745033, G4711476208, European Network for Genetic and Genomic Epidemiology, Anwendung von DNA-Array-Technologien in Molekularer Medizin und Mikrobiologie, G4818431986, G486964816, G4874926547, G4950591047, Verbesserung der Leistungsfähigkeit der klinischen Forschung besonders in den Schwerpunkten Community Medicine und Molekulare Medizin, Phase II, Why have large genome scans of common variation not explained more of the familial risk for diseases?, Kompetenznetz Adipositas: Verbund 'PREVENT', Teilprojekt 3, G5176409192, G5235940078, Unlocking the European Union convergence region potential in genetics, A GENOME-WIDE ASSOCIATION DATABASE OF THE ROTTERDAM STUDY, G5474452856, G5479347414, Verbundvorhaben: Frühmanifeste Adipositas: Genetische Mechanismen und physiologische Implikationen, Teilprojekt 1, Evaluation einer Beratung zu genetischen Aspekten bei Adipositas, G5568298347, G5594960057, G5599442719, Mapping Genes for typical migraine using twin families., G5652896194, G5702163051, Accurate prediction of individual risk to disease using multiple genetic risk factors, Verbundprojekt: Atherogenomics - Teilprojekt, A1, A2, B2, C2, D1, D2, F1: Identifizierung und Charakterisierung von Risikogenen für Herzinfarkt und coronare Herzkrankheit, Verbundkoordination, G5810988395, Evaluation einer Beratung zu genetischen Aspekten bei Adipositas, G6091493096, G6154452564, G616188461, G6229538190, G6323180499, G6518651994, « Inter Arma Helvetia » Swiss humanitarian action during the Great War, Asymmetric Catalysis, G6612309939, Genetics of moliness, G6729743441, Living Rights - Theorizing children's rights in international development, Uncoupled Research Fellowship, Training Overparametrized Models with SGD: the Impact of Noise, G6902273418, Genetics of moliness, G6994344002, Twin-family database for behavior genetics and genomics studies, An alternative scenario for the formation and differentiation of terrestrial planets: core formation in planetesimals, Family formation and labour force participation in light of social security reform, G7333524540, Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3, G7407607593, G7477626106, Risk Factors for Breast Cancer in Younger Nurses, G7726711067, ReliabilitY of opto-Transceivers for Health Monitoring Systems, G7884932760, Women's Health Study: Continued Follow-up, Short- and long-term impacts of career counseling: Investigation of cognitive and relational components, G7943099457, G8129060877, G8210461904, G8378694876, G856913103, Examining stakeholder engagement about bio-banking, and if and how the concept of social licence maybe useful: The KEMRI-Wellcome Trust Research Programme (KWTRP) as a case study, G8678392640, Verbesserung der Struktur- und Leistungsfähigkeit der klinischen Forschung besonders in den Schwerpunkten Community Medicine und Molekulare Medizin, Biobanking and Biomolecular Resources Research Infrastructure, G8753724018, G8779995270, G890705022, G8927421343, Statistical Methods and Algorithms for Analysis of High-throughput Genetics and Genomics Platforms, Nutrition Obesity Research Center (NORC), G915808470, G970400076
OpenAlex ID: W6999499965
